on Cheplapharm Arzneimittel GmbH (isin : DE000CHP2222)
CHEPLAPHARM's €750M Bond Sees High Demand and Attractive Pricing
On June 26, 2025, CHEPLAPHARM Arzneimittel GmbH successfully placed €750 million in senior secured notes with a 7.125% interest rate. This move is aimed at facilitating the early redemption of €500 million notes due in 2027 and partially refinancing notes maturing in 2028, enhancing the company's financial flexibility.
Originally targeting €500 million, the demand for CHEPLAPHARM's bonds was so strong that it allowed the company to increase the issue size to €750 million while reducing the coupon to 7.125%. This indicates strong investor confidence following a challenging financial year in 2024.
The notes, set to mature in 2031, will be issued on July 2, 2025, with Deutsche Bank and J.P. Morgan acting as joint coordinators.
R. H.
Copyright © 2025 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all Cheplapharm Arzneimittel GmbH news